<DOC>
	<DOC>NCT00394160</DOC>
	<brief_summary>The purpose of this study is to look at the preliminary safety profile of an investigational drug in children 1 to &lt; 3 months of age with bronchiolitis.</brief_summary>
	<brief_title>Safety and Pk Study in 1- to 3- Month-Old Children With Bronchiolitis (0476-297)</brief_title>
	<detailed_description />
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Inclusion Criteria : Active bronchiolitis and a history of bronchiolitis and asthmalike symptoms. Exclusion Criteria : Anemia or history of any significant illness that will pose additional risk to the patient.</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>